SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Feb 13, 2017

2. SEC Identification Number

34218

3. BIR Tax Identification No.

000-153-610-000

4. Exact name of issuer as specified in its charter

AYALA CORPORATION

5. Province, country or other jurisdiction of incorporation

PHILIPPINES

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

32F to 35F , Tower One and Exchange Plaza, Ayala Triangle, Ayala Avenue, Makati City Postal Code 1226

8. Issuer's telephone number, including area code

(02)908-3000

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common Shares	620,716,154
Preferred B Series 1 Shares	20,000,000
Preferred B Series 2 Shares	27,000,000
Voting Preferred Shares	200,000,000

11. Indicate the item numbers reported herein

Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Ayala CorporationAC

PSE Disclosure Form 4-13 - Clarification of News Reports References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Clarification of News Article: “Ayala to expand healthcare business”

Source	philstar.com
Subject of News Report	“Ayala to expand healthcare business”
Date of Publication	Feb 13, 2017

Clarification of News Report
This refers to your request to clarify the news article entitled “Ayala to expand healthcare business” posted in the February 13, 2017 issue of Philstar.com. The article reported in part that: “Conglomerate Ayala Corp. (AC) seeks to expand and complete its healthcare portfolio by venturing into medicine manufacturing and healthcare finance. At present, these two segments are the only missing components in the group’s growing healthcare business. According to AC chief finance officer Jose Teodoro Limcaoco, the healthcare industry is comprised of three segments – medicines, healthcare and healthcare finance. The medicine component, he said, includes distribution and manufacturing. ‘We have distribution through Generika Drugstore. We are also looking into manufacturing,’ Limcaoco said. . . . . ‘To me the third leg that is missing is what I call healthcare finance. If you get sick who pays? You have health insurance right. But only four million Filipinos are covered by insurance out of 100 million. That’s private insurance. And then there’s Philhealth but you have to be employed to have Philhealth,’ Limcaoco said ‘We just know that there’s something missing there. So we think there’s space but we don’t know how to get into it. We’re still looking,’ he said. . . . .” We wish to confirm that Ayala is examining all aspects of the healthcare space. We wish to however clarify that these are all exploratory and no deal is imminent at this time.
Other Relevant Information
-